Illinois Hospital Report Card

and Consumer Guide to Health Care

UI Health

Patient Safety - CDI & MRSA

Clostridioides difficile infections (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections

Facility-wide Healthcare Facility Onset Incidence Rates for CDI and MRSA are presented below. These rates are based on results of laboratory tests that were obtained on or after day four of an inpatient stay and do not consider presence or timing of clinical signs or symptoms. The Standardized Infection Ratio (SIR) is presented, which is a summary measure used to determine if rates of CDI and MRSA bloodstream infections are statistically different from the national average. Statewide summaries of CDI and MRSA data arranged by hospital are also included. Note: Starting with 2016 data, new methods for risk adjustment were used.

Statistical Significance

Statistically significantly better than the national average or performing at the best possible rate

Not statistically significantly better or worse than the national average

Statistically significantly worse than the national average

Healthcare Facility Onset Incidence Rate	Result	SIR
Methicillin-resistant Staphylococcus aureus (MRSA) blood stream infections Q1 2024 - Q4 2024 Result 6 infections, 129179 patient days Rating SIR: 0.53	6 infections, 129179 patient days	0.53
Description Methicillin-resistant Staphylococcus aureus infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2023 - Q4 2023 Result 10 infections, 126841 patient days Rating SIR: 1.07	10 infections, 126841 patient days	1.07
Q1 2022 - Q4 2022 Result 13 infections, 122274 patient days Rating SIR: 1.40	13 infections, 122274 patient days	1.40
Q1 2021 - Q4 2021 Result 9 infections, 120814 patient days Rating SIR: 0.73	9 infections, 120814 patient days	0.73
Q1 2020 - Q4 2020 Result 10 infections, 108984 patient days Rating SIR: 0.91	10 infections, 108984 patient days	0.91
Q1 2019 - Q4 2019 Result 9 infections, 121102 patient days Rating SIR: 0.81	9 infections, 121102 patient days	0.81
Q1 2018 - Q4 2018 Result 7 infections, 115696 patient days Rating SIR: 0.70	7 infections, 115696 patient days	0.70
Q1 2017 - Q4 2017 Result 6 infections, 112157 patient days Rating SIR: 0.55	6 infections, 112157 patient days	0.55
Q1 2016 - Q4 2016 Result 6 infections, 114603 patient days Rating SIR: 0.66	6 infections, 114603 patient days	0.66
Q1 2015 - Q4 2015 Result 7 infections, 116831 patient days Rating SIR: 0.78	7 infections, 116831 patient days	0.78
Q1 2014 - Q4 2014 Result 9 infections, 119342 patient days Rating SIR: 0.84	9 infections, 119342 patient days	0.84
Q1 2013 - Q4 2013 Result 9 infections, 118405 patient days Rating SIR: 0.78	9 infections, 118405 patient days	0.78
Q1 2012 - Q4 2012 Result 13 infections, 121877 patient days Rating SIR: 1.09	13 infections, 121877 patient days	1.09
Q1 2012 - Q2 2012 Result 9 infections, 61180 patient days Rating SIR: 1.47	9 infections, 61180 patient days	1.47
Clostridioides difficile infections (CDI) Q1 2024 - Q4 2024 Result 16 infections, 119702 patient days Rating SIR: 0.29	16 infections, 119702 patient days	0.29
Description Clostridium difficile infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2023 - Q4 2023 Result 25 infections, 116853 patient days Rating SIR: 0.42	25 infections, 116853 patient days	0.42
Q1 2022 - Q4 2022 Result 49 infections, 113565 patient days Rating SIR: 0.59	49 infections, 113565 patient days	0.59
Q1 2021 - Q4 2021 Result 82 infections, 112584 patient days Rating SIR: 1.04	82 infections, 112584 patient days	1.04
Q1 2020 - Q4 2020 Result 77 infections, 100429 patient days Rating SIR: 0.85	77 infections, 100429 patient days	0.85
Q1 2019 - Q4 2019 Result 98 infections, 111634 patient days Rating SIR: 0.97	98 infections, 111634 patient days	0.97
Q1 2018 - Q4 2018 Result 129 infections, 106705 patient days Rating SIR: 1.30	129 infections, 106705 patient days	1.30
Q1 2017 - Q4 2017 Result 113 infections, 102571 patient days Rating SIR: 1.20	113 infections, 102571 patient days	1.20
Q1 2016 - Q4 2016 Result 109 infections, 112315 patient days Rating SIR: 1.04	109 infections, 112315 patient days	1.04
Q1 2015 - Q4 2015 Result 116 infections, 115726 patient days Rating SIR: 1.05	116 infections, 115726 patient days	1.05
Q1 2014 - Q4 2014 Result 114 infections, 115338 patient days Rating SIR: 1.22	114 infections, 115338 patient days	1.22
Q1 2013 - Q4 2013 Result 91 infections, 114631 patient days Rating SIR: 0.82	91 infections, 114631 patient days	0.82
Q1 2012 - Q4 2012 Result 106 infections, 117771 patient days Rating SIR: 1.39	106 infections, 117771 patient days	1.39